(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | 17.19%-785.8K | -948.97K |
Payments to suppliers for goods and services | 17.19%-785.8K | ---948.97K |
Direct interest received | --52.06K | ---- |
Operating cash flow | 22.68%-733.74K | ---948.97K |
Investing cash flow | ||
Cash flow from continuing investing activities | -3.90%-1.58M | -1.52M |
Capital expenditure reported | -2.46%-951.96K | ---929.14K |
Net PPE purchase and sale | 99.02%-5.82K | ---594.27K |
Net business purchase and sale | ---25K | ---- |
Net investment purchase and sale | ---600K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -3.90%-1.58M | ---1.52M |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.15%-11.25K | 7.66M |
Net issuance payments of debt | -144.45%-31.25K | --70.31K |
Net common stock issuance | ---- | --7.7M |
Net other financing activities | 118.04%20K | ---110.88K |
Cash from discontinued financing activities | ||
Financing cash flow | -100.15%-11.25K | --7.66M |
Net cash flow | ||
Beginning cash position | 518,857,800.00%5.19M | --1 |
Current changes in cash | -144.86%-2.33M | --5.19M |
End cash Position | -44.86%2.86M | --5.19M |
Free cash from | 31.58%-1.69M | ---2.47M |
Accounting Standards | US-GAAP | US-GAAP |
No Data